JSM 2004 - Toronto

Keyword Search
Keyword=clinical trial

This is the preliminary program for the 2004 Joint Statistical Meetings in Toronto, Canada. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2004); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

Back to main JSM 2004 Program page
  300573  By:    3:05 PM 08/08/2004
A Case Study of a Group-sequential Response Adaptive Clinical Trial

  301325  By:    08/09/2004
Checking Model Assumptions--Getting the BUGS Out

  301612  By:    08/09/2004
Modeling Tumor Growth in Cancer Clinical Trial

  301373  By:    11:20 AM 08/09/2004
A Simple Hybrid Variance Estimator for the Kaplan-Meier Survival Function

  301810  By:    11:35 AM 08/09/2004
Designing an Optimal Futility Analysis for an Equivalence Trial Using Simulation and Historical Data

  300538  By:    12:05 PM 08/09/2004
Alternative Approach for Estimating Tumor Response Rate

  301648  By:    2:25 PM 08/09/2004
Statistical Analysis of Stratified Missing-at-random Designs for Large Clinical Trials

  301372  By:    3:35 PM 08/09/2004
Modified Intention-to-treat Analysis in Clinical Trials

  301027  By:    11:50 AM 08/10/2004
SCPRT: A Sequential Procedure Giving Another Reason to Stop a Trial Early

  301647  By:    12:05 PM 08/10/2004
Comparison of Treatment Effects Using Empirical Bayes Method

  301298  By:    2:20 PM 08/10/2004
Issues in the Application of Microarray Data in a Clinical Trial

  301530  By:    2:25 PM 08/10/2004
Implementation of Backward Induction for Sequentially Adaptive Clinical Trials

  300738  By:    8:35 AM 08/11/2004
A Statistical Framework for Characterizing Informed Cross-over in Phase III Clinical Trial

  300463  By:    11:35 AM 08/11/2004
Setting Tolerance Limits in Clinical Trials with Dichotomous Outcomes

  300852  By:  Guowen (Gordon) Sun 2:45 PM 08/11/2004
Comparison of Methods for Missing Data Imputations in the Analysis of Radiographic Data from a Large Phase III Trial

  300922  By:    3:25 PM 08/11/2004
Regulatory Guidelines and FDA's Perspective on the Collection and Analysis of the Radiographic Data in Rheumatoid Arthritis Clinical Trials

  300825  By:    9:15 AM 08/12/2004
Clinical Trials Data-monitoring Committees: The Who, What, When, and Why of Unmasking

  301945  By:    9:50 AM 08/12/2004
Statistical Validation of Surrgoate Endpoints in HCV Clinical Studies

JSM 2004 For information, contact jsm@amstat.org or phone (888) 231-3473. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2004